The tumor-suppressive role of PTPN11 in HCC is mediated through the IκB kinase/NF-κB (IKK/NF-κB) pathway through promoting IL-6-stimulated Stat3 activation [45,46]. This evidence concerns the gene STAT3 and neoplasm.